• Dassault Systèmes agreed to buy ArisGlobal for about USD 1.8 billion in cash, with up to USD 200 million tied to multi-year AI revenue milestones.
• Deal targets a unified AI platform for life sciences, combining ArisGlobal’s regulated operations and real-world evidence with Dassault’s R&D and manufacturing capabilities.
• ArisGlobal serves more than 200 customers, including half of the top 50 global biopharma companies, processing over 12 million patient safety reports annually.
• ArisGlobal has more than 1,300 employees, with expected 2026 revenue of USD 175 million.
• Closing is expected in the second half of 2026, subject to regulatory approvals and customary conditions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Dassault Systèmes SE published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607230057OMX_____CNEWS_EN_GNW1001214036_en) on July 23, 2026, and is solely responsible for the information contained therein.